User profiles for Ron Korn

Ron Korn

Radiology
Verified email at imagingendpoints.com
Cited by 1079

[HTML][HTML] Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial

…, DA Laheru, LS Smith, TE Wood, RL Korn… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose The trial objectives were to identify the maximum-tolerated dose (MTD) of first-line
gemcitabine plus nab-paclitaxel in metastatic pancreatic adenocarcinoma and to provide …

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study

…, G Alva, CF Longmire, G Jewell, KA Johnson, R Korn… - Neurology, 2012 - AAN Enterprises
Objectives: Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living
subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using …

First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion …

…, F Tsai, M Farwell, TC Mitchell, R Korn… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Immunotherapy is becoming the mainstay for treatment of a variety of malignancies, but only
a subset of patients responds to treatment. Tumor-infiltrating CD8-positive (CD8+) T …

CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody

…, MD Hellmann, JJ Harding, R Korn… - Journal of Nuclear …, 2022 - Soc Nuclear Med
There is a need for in vivo diagnostic imaging probes that can noninvasively measure tumor-infiltrating
CD8+ leukocytes. Such imaging probes could be used to predict early response …

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

…, M Yeager, V Dilsizian, BP Griffith, R Korn… - Circulation, 2005 - Am Heart Assoc
Background— Successful autologous skeletal myoblast transplantation into infarcted
myocardium in a variety of animal models has demonstrated improvement in cardiac function. We …

Phase Ib study of PEGylated recombinant human hyaluronidase and gemcitabine in patients with advanced pancreatic cancer

…, SA Tjulandin, OA Gladkov, RF Holcombe, R Korn… - Clinical Cancer …, 2016 - AACR
Purpose: This phase Ib study evaluated the safety and tolerability of PEGylated human
recombinant hyaluronidase (PEGPH20) in combination with gemcitabine (Gem), and established …

[PDF][PDF] A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma

…, DS Wang, HJ Kim, CB Sirlin, MG Chan, RL Korn… - …, 2015 - Wiley Online Library
Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an independent predictor
of poor outcomes subsequent to surgical resection or liver transplantation (LT); however, …

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study

…, SJ Knox, S Ning, DM Peehl, R Korn… - The Lancet …, 2015 - thelancet.com
Background Epigenetic alterations have been strongly associated with tumour formation and
resistance to chemotherapeutic drugs, and epigenetic modifications are an attractive target …

[HTML][HTML] Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review

E Borazanci, SZ Millis, R Korn, H Han… - World journal of …, 2015 - ncbi.nlm.nih.gov
Adenosquamous carcinoma of the pancreas (ASCP) is a rare entity. Like adenocarcinoma
of the pancreas, overall survival is poor. Characteristics of ASCP include central tumor …

MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration

…, NL Tran, S Nasser, S Sridhar, RL Korn… - … journal of cancer, 2011 - Wiley Online Library
Brain metastasis (BM) can affect ∼ 25% of nonsmall cell lung cancer (NSCLC) patients during
their lifetime. Efforts to characterize patients that will develop BM have been disappointing…